Provided by Tiger Trade Technology Pte. Ltd.

SKB BIO

472.200
-14.800-3.04%
Volume:349.28K
Turnover:164.29M
Market Cap:112.86B
PE:-285.00
High:500.000
Open:500.000
Low:459.000
Close:487.000
52wk High:581.000
52wk Low:339.600
Shares:239.00M
HK Float Shares:177.00M
Volume Ratio:0.70
T/O Rate:0.20%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.657
ROE:2.92%
ROA:-0.04%
PB:18.07
PE(LYR):-285.00
PS:46.24

Loading ...

Sichuan Kelun-biotech Biopharmaceutical - Primary Endpoint Met for Phase 3 Study of Trop2 ADC Sacituzumab Tirumotecan with Pembrolizumab

THOMSON REUTERS
·
Jul 15

GLMS SEC: Significant Room for Improvement in First-Line Advanced Lung Cancer Treatment; Focus on SKB BIO's Global R&D Progress for sac-TMT

Stock News
·
Jul 14

Movement Alert|Kelun-Biotech Declines 3.17% in Regular Trading, Post-Placement Technical Pullback Continues

Market Focus
·
Jul 14

Movement Alert|Kelun-Biotech Biopharmaceutical Intraday Decline 3.1%, Technical Pullback Following Completion of HK$2.72 Billion Share Placement

Market Focus
·
Jul 13

SKB BIO Releases Updated Articles of Association Following Hong Kong H-Share Listing

Bulletin Express
·
Jul 10

SKB BIO Completes HK$2.72 Billion H-Share Placement; Core Shareholder’s Stake Eases to 62.53%

Bulletin Express
·
Jul 10

SKB BIO Completes HKD 2.75 Billion H-Share Placement, Expanding Issued Capital by 3.41%

Bulletin Express
·
Jul 10

Kelun-biotech Files HKEX Next-day Disclosure Return, Share Capital Rises on 5,838,000 New H Shares Placing

Reuters
·
Jul 10

Kelun-biotech Completes Hk$2.72 Billion H-share Placement at Hk$470.2 Per Share

Reuters
·
Jul 10

Biotech Stocks Surge as New National Essential Drug List Includes Innovative Therapies

Stock News
·
Jul 10

Sichuan Kelun-Biotech Seeks HK$2.7 Billion via Share Placement

MT Newswires Live
·
Jul 08

SKB BIO Announces Share Placement at Discount, Aiming to Raise Approximately HK$2.72 Billion

Stock News
·
Jul 08

Sichuan Kelun-biotech Prices 5,838,000-share H-share Placement at HK$ 470.2

Reuters
·
Jul 08

Sichuan Kelun-biotech Biopharmaceutical - to Place 5.84 Mln New H Shares at Hk$470.2 Per Share

THOMSON REUTERS
·
Jul 08

Kelun-biotech Names Zhou Zejian Sole Company Secretary After Chung Ming Fai Resignation

Reuters
·
Jul 07

Movement Alert|Kelun-Biotech Declines 3.06% in Regular Trading, Trading at HK$506.0

Market Focus
·
Jul 07

Movement Alert|Kelun-Biotech Rises 3.31% in Regular Trading, Multiple Brokerages Maintain Buy Ratings Amid ASCO Data Momentum

Market Focus
·
Jul 06

Movement Alert|Kelun-Biotech Rises 4.79% in Regular Trading, ASCO Phase III Data and Multiple Broker Upgrades Continue to Drive Momentum

Market Focus
·
Jul 03

Is Sichuan Kelun Biotech Biopharmaceutical (SEHK:6990) Cheap On New Cancer Cell Research?

Simply Wall St.
·
Jul 03

Market Analysis: Meta's AI Compute Sale Not a Bearish Signal; Healthcare Stocks Surge on Multiple Catalysts

Stock News
·
Jul 02